glp-1 obesity drug news today october 2025 WHO Decision Recognizing as a Disease Treatable with Drugs Is “Big Deal,” says BU Endocrinologist | BU Study identifies benefits, risks linked

As your skin adjusts, you can gradually increase to twice daily use if needed

Stacked Protocol (Cagrilintide + Smglutd) Dose: 0.6 2.4 mg Cagrilintide + 0.25 2.4 mg Smglutd (= 2496 clicks) Duration: 12 20 weeks Frequency: Once weekly, co-administered Cycle Interval: 4 6 weeks off before repeating Goal / Description: Dual amylin and GLP-1 receptor activation studied for enhanced metabolic and weight outcomes

Most patients self-inject at home with a 30 gauge insulin syringe

Our wellness pen combination refill kit contains our two premium at-home refill kits, with one months supply of NAD+ and L-Glutathione

For a subcutaneous injection, which goes into the fatty tissue just beneath the skin, a 45-degree angle is best

The changes will be long lasting